Nemonapride

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Nemonapride
Nemonapride.svg
Clinical data
Trade namesEmilace (JP)
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Oral
ATC code
  • none
Legal status
Legal status
  • Rx-only (JP)
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
PDB ligand
Chemical and physical data
FormulaC21H26ClN3O2
Molar mass387.90 g/mol g·mol−1
3D model (JSmol)
  (verify)

Nemonapride (エミレース, Emilace (JP)) is an atypical antipsychotic approved in Japan for the treatment of schizophrenia. It was launched by Yamanouchi in 1991. Nemonapride acts as a D2 and D3 receptor antagonist, and is also a potent 5-HT1A receptor agonist. It has affinity for sigma receptors.

See also[edit]

References[edit]